AGP
RNAM

Artia Global Partners’s Avidity Biosciences RNAM Stock Holding History

Artia Global Partners’s Portfolio RNAM Stock Details RNAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-60,100
Closed -$4.34M – 58
2025
Q4 		$4.34M Sell
60,100
-50,000
-45% -$3.23M 0.61% 26
2025
Q3 		$4.8M Buy
110,100
+75,500
+218% +$3.05M 0.76% 21
2025
Q2 		$983K Buy
+34,600
New +$1.03M 0.24% 32

Other funds holding RNAM

CC
Corsicana & Co Corsicana, Texas $158M AUM

Artia Global Partners's RNAM Position: Q1 2026 in Review

Artia Global Partners sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 60,100 shares — an estimated $4.34M sold.

Artia Global Partners first reported a position in RNAM in Q2 2025 and held it in 3 quarters. The position peaked at $4.8M in Q3 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.

  • Artia Global Partners reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
  • Artia Global Partners sold 60,100 Avidity Biosciences shares in Q1 2026, an estimated $4.34M.
  • Artia Global Partners first reported a position in Avidity Biosciences in Q2 2025 and held it in 3 quarters.
  • Artia Global Partners's Avidity Biosciences position peaked at $4.8M in Q3 2025.
  • 1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.

Based on Artia Global Partners's 13F filing for Q1 2026, filed 15 May 2026.